Article
The super-enhancer landscape reflects molecular subgroups of adrenocortical carcinoma
medRxiv · 2023 · Gunz, S.; Kerdivel, G.; Meirer, J.; Shapiro, I.; Regazzon, B.; Amrouche, F.; Calmejane, M.-A.; Hamroune, J.; Sigala, S.; Berruti, A.; Bertherat, J.; Assie, G.; Hantel, C.; Boeva, V.
Key facts
| Title | The super-enhancer landscape reflects molecular subgroups of adrenocortical carcinoma |
|---|---|
| First author | Gunz, S.; Kerdivel, G.; Meirer, J.; Shapiro, I.; Regazzon, B.; Amrouche, F.; Calmejane, M.-A.; Hamroune, J.; Sigala, S.; Berruti, A.; Bertherat, J.; Assie, G.; Hantel, C.; Boeva, V. |
| Journal | medRxiv |
| Published | Apr 14, 2023 |
| DOI | 10.1101/2023.04.05.535576 |
| Devices mentioned | K190495 |
| Product codes mentioned | DDG, PCA, JJH, KIT, NDS, PFF, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1